Skip to content

Alumis Inc.

ALMS· NasdaqCore metricsCIK 1847367

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -7.19%
Market cap
$796.45M
129.82M shares
Filings
251
$1.91M
Q3 2026
—
-$94.88M
Q3 2026N/M FY25 yoy
-$99.08M
Q3 2026N/M FY25 yoy
-$249.02M
Q3 2026derivedN/M FY25 yoy
-$0.73
Q3 2026N/M FY25 yoy
$57.69M
Q3 2026−47.1% FY25 yoy
$796.45M
—
110.0×
2.1×
-40.29%
—

Twelve months to Sep 30, 2026 · derived

Price

$6.14+15.75%+$0.84past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$24.05MFY 2025
$24.05M0FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$24,050,000reported

Capital returns

Dividends and buybacks · FY2023 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$17.00K$17.00K————
FY2024—$6.00K$6.00K————
FY2023—$64.00K$64.00K————

Segments

Products
Revenue by Products, FY2025 to FY2025FY2025License · FY2025 · $17.39MCollaboration · FY2025 · $6.66M
LineFY2025ShareChange
License$17.39M72%—
Collaboration$6.66M28%—
Total$24.05M

From the 10-K filed Mar 19, 2026ALMS

Pharmaceutical preparations

Alumis Inc. is the 150th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Alumis Inc. · CIK 1847367 · Engraved from SEC EDGAR